SCHEMBL18796195

SCHEMBL18796195

Cc1nc2ccccc2cc1Oc1ccc(Cl)cc1Br

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 7/20 0.54
▸ HTT P42858 5/20 0.54
▸ MAPT P10636 5/20 0.54
▸ LMNA P02545 4/20 0.54
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ STAT3 P40763 3/20 0.46
▸ SLC6A2 P23975 3/20 0.43
▸ SLC6A4 P31645 3/20 0.43
▸ POLB P06746 1/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ SLC6A3 Q01959 1/20 0.41
▸ HPGD P15428 3/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ EPAS1 Q99814 1/20 0.38
▸ TLR8 Q9NR97 1/20 0.38
▸ S1PR4 O95977 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18796132 0.84 SMN1; SMN2 (0.51) SMN1; SMN2HTTMAPTLMNAL3MBTL1
SCHEMBL18796439 0.83 HTT (0.54) SMN1; SMN2HTTMAPTLMNAL3MBTL1
SCHEMBL18796297 0.78 MAPT (0.48) SMN1; SMN2HTTMAPTLMNAL3MBTL1
SCHEMBL18796074 0.75 NPC1 (0.44) SMN1; SMN2HTTMAPTLMNAL3MBTL1
SCHEMBL20551887 0.75 SMN1; SMN2 (0.46) SMN1; SMN2HTTMAPTLMNAL3MBTL1
SCHEMBL21670812 0.73 L3MBTL1 (0.48) SMN1; SMN2HTTMAPTLMNAL3MBTL1
SCHEMBL29207072 0.72 HTT (0.59) SMN1; SMN2HTTMAPTLMNAL3MBTL1
SCHEMBL18796155 0.72 SMN1; SMN2 (0.51) SMN1; SMN2HTTMAPTLMNAL3MBTL1
SCHEMBL18796216 0.72 HTT (0.51) SMN1; SMN2HTTMAPTLMNAL3MBTL1
SCHEMBL18796468 0.71 SMN1; SMN2 (0.50) SMN1; SMN2HTTMAPTLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3368514-B1 TRISUBSTITUTED SILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AG (DE) 2021-08-18 — — EP disclosed
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-06-16 — — US disclosed
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-08-01 — — US disclosed
EP-3368514-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES Bayer CropScience Aktiengesellschaft (DE) 2018-09-05 — — EP disclosed
WO-2017072283-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-05-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10683311-B2 Trisubstitutedsilylphenoxyheterocycles and analogues PIK3C3, ERG28, DDT SMN1; SMN2 4243/4885HTT 3740/4885MAPT 3403/4885
US-20190233444-A1 TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES PIK3C3, ERG28, DDT SMN1; SMN2 4243/4885HTT 3740/4885MAPT 3403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback